Levine Jon R purchased $230 of MRMD
Levine Jon R (President and CEO) purchased 3,000 shares of MARIMED INC. (MRMD) at $0.08 on 2026-05-22.
How this was made
The 30-second read
Why it matters
Insider buying can support sentiment, but the disclosed trade size is very small and lacks any operational or financial catalyst in the article.
Market read
Traders may monitor MRMD for continued insider buying, but this specific filing alone is unlikely to drive a durable repricing.
What to watch
Check whether there are additional Form 4s (especially larger buys/sells) around the same period and whether the stock price was volatile before 2026-05-22.
Background
The article is an SEC Form 4 insider transaction disclosure for MARIMED Inc. (MRMD).
Ticker impact
MRMD CEO/President Jon R Levine filed an open-market purchase of 3,000 shares on 2026-05-22, signaling insider buying activity.
Near-term impact likely limited; any reaction may be transient unless followed by larger buys or operational catalysts.
The transaction is an SEC Form 4 insider purchase with low dollar value ($230) and no accompanying corporate event disclosed in the filing text.
Market effects
No sector read-across provided; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
A $230 open-market buy may reflect routine compensation/portfolio rebalancing rather than a strong bullish thesis.
Key entities
- issuerMARIMED Inc.
MRMD; CEO/President Jon R Levine reported an open-market purchase of 3,000 shares at $0.0767 on 2026-05-22.
- insiderLevine Jon R
President and CEO; reported direct holdings increase to 21,250,986 shares after the purchase.